Facebook tracking pixel
E27.0
ICD-10-CM
Elevated DHEA

Understanding Elevated DHEA: Explore information on high DHEA levels, DHEA excess, and their clinical significance. This resource covers diagnosis, medical coding, and documentation best practices for healthcare professionals dealing with elevated DHEA. Learn about related laboratory tests, potential causes, and treatment considerations for patients with high DHEA. Find essential information for accurate clinical documentation and efficient medical coding related to elevated DHEA.

Also known as

High DHEA levels
DHEA excess

Diagnosis Snapshot

Key Facts
  • Definition : High levels of the hormone DHEA, often caused by adrenal gland issues.
  • Clinical Signs : Acne, hirsutism, irregular periods, masculinization in females, early puberty in children.
  • Common Settings : Endocrinology clinics, fertility clinics, pediatric endocrinology.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC E27.0 Coding
E28-E35

Disorders of adrenal gland

Includes conditions causing excess adrenal hormone production, like DHEA.

E00-E89

Endocrine, nutritional, and metabolic diseases

Broader category encompassing hormonal imbalances, including elevated DHEA.

R79.89

Other specified abnormal findings of blood chemistry

Can be used for unspecified abnormal lab results, possibly including high DHEA.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the elevated DHEA due to an adrenal gland disorder?

Code Comparison

Related Codes Comparison

When to use each related code

Description
High DHEA hormone levels.
Adrenal gland tumor producing excess hormones.
Group of symptoms due to excess androgens in women.

Documentation Best Practices

Documentation Checklist
  • Document DHEA sulfate (DHEA-S) lab result value and units.
  • Specify source of elevated DHEA (adrenal or ovarian).
  • Record signs/symptoms related to high DHEA (hirsutism, acne).
  • Document related diagnoses (PCOS, adrenal tumor).
  • Note any DHEA-related medications or supplements.

Coding and Audit Risks

Common Risks
  • Unspecified DHEA Type

    Coding requires specifying DHEA-S or DHEA sulfate. Unspecified DHEA may lead to claim denials or inaccurate reporting.

  • Lack of Clinical Validation

    Elevated DHEA needs supporting documentation like lab results. Missing details can trigger audits and compliance issues.

  • Underlying Cause Uncoded

    Coding should include the underlying cause of elevated DHEA, if known, for accurate clinical documentation and reimbursement.

Mitigation Tips

Best Practices
  • Review medications: Steroids can elevate DHEA.
  • Confirm diagnosis: Repeat DHEA sulfate test.
  • Image adrenal glands: Rule out tumors.
  • Consider PCOS in females: DHEA excess is common.
  • Lifestyle changes: Manage stress, improve sleep.

Clinical Decision Support

Checklist
  • Verify elevated DHEA-S lab result: units, reference range.
  • Confirm patient age, sex, and relevant medical history (e.g., hirsutism, PCOS).
  • Exclude adrenal or ovarian tumor: imaging, hormonal evaluation.
  • Assess for medications that may affect DHEA-S levels.
  • Document DHEA-S level, related findings, and plan in patient record.

Reimbursement and Quality Metrics

Impact Summary
  • Elevated DHEA reimbursement impacts depend on diagnosis code accuracy (ICD-10 E25.8 or related) and medical necessity documentation for associated testing and treatment.
  • Coding accuracy for Elevated DHEA (E25.8) directly affects hospital revenue cycle management and claim denial rates. Proper coding ensures appropriate reimbursement.
  • Quality metrics impacted by Elevated DHEA diagnosis may include endocrine disorder management, hormone level monitoring, and patient follow-up adherence.
  • Accurate reporting of Elevated DHEA (High DHEA levels, DHEA excess) influences hospital quality reporting and performance benchmarks related to hormonal disorders.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the common differential diagnoses to consider in women presenting with elevated DHEA and hirsutism?

A: When a female patient presents with elevated DHEA and hirsutism, clinicians must consider a range of differential diagnoses beyond the common culprits like Polycystic Ovary Syndrome (PCOS). Adrenal disorders, such as adrenal hyperplasia (both congenital and non-classic) and adrenal tumors (including adrenal adenomas and carcinomas), should be investigated. These conditions can lead to excessive DHEA production. Ovarian tumors, although less common, can also contribute to elevated DHEA and hirsutism. Cushing's syndrome, while less frequently associated with hirsutism, can also cause elevated DHEA and warrants consideration. Certain medications can interfere with hormone levels, so a thorough medication review is crucial. Explore how age-specific reference ranges for DHEA can aid in accurate diagnosis and consider implementing a diagnostic algorithm that includes evaluating DHEA-S levels, imaging studies (like adrenal ultrasound or CT scan), and genetic testing when indicated to pinpoint the underlying cause.

Q: How do I interpret elevated DHEA levels in a premenopausal woman without overt signs of hyperandrogenism like hirsutism or acne?

A: Elevated DHEA levels in a premenopausal woman without overt signs of hyperandrogenism like hirsutism or acne can be a diagnostic challenge. It requires careful consideration of several factors. Firstly, confirm the elevation is persistent with repeat testing, ruling out lab error or transient fluctuations. Secondly, assess for subtle signs of hyperandrogenism, like irregular menstrual cycles or changes in body composition. Mildly elevated DHEA levels might be subclinical or indicative of early-stage PCOS. Consider implementing an expanded hormonal panel, including testosterone, androstenedione, SHBG, FSH, and LH, to help distinguish between various potential etiologies. Adrenal sources of DHEA excess, such as mild adrenal hyperplasia, need investigation. Explore how lifestyle factors, such as stress and obesity, can influence DHEA levels. Finally, consider implementing long-term monitoring for disease progression and exploring lifestyle modifications that can help manage DHEA levels and mitigate potential long-term health risks.

Quick Tips

Practical Coding Tips
  • Code elevated DHEA, not symptoms
  • Check DHEA sulfate levels
  • Query physician if DHEA cause unclear
  • Use ICD-10 E25.0 for adrenal DHEA
  • Consider SNOMED CT for DHEA excess

Documentation Templates

Patient presents with signs and symptoms suggestive of elevated Dehydroepiandrosterone (DHEA) levels.  Clinical findings include hirsutism, acne, oligomenorrhea, and virilization.  The patient reports increased hair growth, irregular periods, and skin changes.  Differential diagnoses considered include polycystic ovary syndrome (PCOS), adrenal hyperplasia, and adrenal tumor.  Laboratory results reveal a significantly elevated DHEA-sulfate (DHEA-S) level, confirming the diagnosis of high DHEA.  The patient's medical history is notable for normal menarche and no known family history of endocrine disorders.  Treatment plan includes further investigation to determine the underlying cause of DHEA excess.  This may involve imaging studies of the adrenal glands such as CT or MRI scan, and additional hormonal assays including testosterone, androstenedione, and 17-hydroxyprogesterone.  Patient education provided on the potential implications of elevated DHEA and the importance of follow-up care.  ICD-10 code E28.2 (Adrenal androgen hyperfunction) is considered for medical billing and coding purposes.  The patient will be scheduled for follow-up to review imaging results and discuss management options, which may include medication to regulate DHEA production or referral to an endocrinologist for specialized care.